ResearcherIran University of Medical SciencesActive in the last 2 years

Ali‐Akbar Delbandi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0012-9333; OpenAlex author ID A5047548963. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

Current and future immunotherapeutic approaches in pancreatic cancer treatment. Last author DOI 10.1186/s13045-024-01561-6 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pooya Farhangnia · 1 shared paper, 2024 · strength 0.31
- Paper Current and future immunotherapeutic approaches in pancreatic cancer treatment. DOI 10.1186/s13045-024-01561-6 ↗
Hamid Nickho · 1 shared paper, 2024 · strength 0.31
- Paper Current and future immunotherapeutic approaches in pancreatic cancer treatment. DOI 10.1186/s13045-024-01561-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.